3 Win Nobel Medicine Prize for Discovering Hepatitis C Virus
(STOCKHOLM) — Americans Harvey J. Alter and Charles M. Rice and British-born scientist Michael Houghton won the Nobel Prize for medicine on Monday for their discovery of the hepatitis C virus, a major source of liver disease that affects millions worldwide.
Announcing the prize in Stockholm, the Nobel Committee noted that the trio’s work identified a major source of blood-borne hepatitis that couldn’t be explained by the previously discovered hepatitis A and B viruses. Their work, dating back to the 1970s and 1980s, has helped saved millions of lives, the committee said.
“Thanks to their discovery, ...
Source: TIME: Science - October 5, 2020 Category: Science Authors: DAVID KEYTON and FRANK JORDANS / AP Tags: Uncategorized News News Desk wire Source Type: news
Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemi c therapy. Based on this recommendation, a final decision regarding approval of Tecentriq in combination with Avastin in this disease setting, along with the full details of the approved indication, is expected from ...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news
Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemi c therapy. Based on this recommendation, a final decision regarding approval of Tecentriq in combination with Avastin in this disease setting, along with the full details of the approved indication, is expected from ...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news
Researchers discover gene that could decrease likelihood of developing alcoholic cirrhosis
(Indiana University School of Medicine) Researchers at Indiana University School of Medicine are learning more about how a person's genes play a role in the possibility they'll suffer from alcoholic cirrhosis with the discovery of a gene that could make the disease less likely. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 11, 2020 Category: International Medicine & Public Health Source Type: news
Tools Emerging to Predict Liver Failure in Cirrhosis Tools Emerging to Predict Liver Failure in Cirrhosis
Systemic inflammation and portal hypertension can help predict whether a patient hospitalized for acute decompensated cirrhosis will develop acute-on-chronic liver failure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
New gene associated with reduced risk for cirrhosis
NIH-funded study provides hope for better disease prediction. (Source: NIAAA News)
Source: NIAAA News - August 31, 2020 Category: Addiction Authors: Katherine Source Type: news
New gene associated with reduced risk for cirrhosis
NIH-funded study provides hope for better disease prediction. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 31, 2020 Category: American Health Source Type: news
Depression and anxiety are common among patients with cirrhosis - Hernaez R, Kramer JR, Khan A, Phillips J, McCallister K, Chaffin K, Hernandez AP, Fullington H, Ortiz C, Blackwell JM, Loewen A, Liu Y, Tiro JA, Lee SC, Singal AG.
BACKGROUND AIMS: Depression and anxiety can have negative effects on patients and are important to treat. There have been few studies of their prevalence among patients with cirrhosis. We aimed to characterize the prevalence and risk factors for depression... (Source: SafetyLit)
Source: SafetyLit - August 30, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Fecal Transplant Shows Promise in Reducing Alcohol Craving Fecal Transplant Shows Promise in Reducing Alcohol Craving
Fecal transplantation for end-stage cirrhosis improves microbiome diversity, reduces alcohol cravings, and improves quality of life, a new safety study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 28, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
When liver cirrhosis is deadly
(Goethe University Frankfurt) A study by an international team of researchers headed by Professor Jonel Trebicka from the Frankfurt University Hospital and funded by the foundation EF Clif, has discovered which patients are particularly at risk for acute-on-chronic liver failure. With their findings, the scientists have laid the foundation for the development of preventive therapy to prevent acute-on-chronic liver failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2020 Category: International Medicine & Public Health Source Type: news
Repeat FIB-4 Blood Tests Help Predict Cirrhosis Repeat FIB-4 Blood Tests Help Predict Cirrhosis
The difference between one fibrosis-4 (FIB-4) score and the next can predict risk for severe liver disease, new research shows, and can provide useful information to primary care doctors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 25, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Strides Pharma gets USFDA nod for Ursodiol tablets, a liver disease treatment drug
Strides Pharma Science gets an approval from the USFDA to market Ursodiol tablets used for treating primary biliary cirrhosis, a progressive disease of the liver caused by a buildup of bile within the liver. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2020 Category: Pharmaceuticals Source Type: news
TGen review suggests postmenopausal women at risk for nonalcoholic fatty liver disease
(The Translational Genomics Research Institute) NAFLD is the most common cause of liver damage, and can lead to liver cirrhosis and death. It affects nearly 1 in 4 people across the globe. It often is associated with obesity, abnormally high amounts of lipids in the blood, and type 2 diabetes. In the US, the number of NAFLD cases is expected to grow to more than 100 million within the next decade, annually costing an estimated at $292 billion. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2020 Category: International Medicine & Public Health Source Type: news
Resoundant expands its clinical research services
Medical technology company Resoundant is expanding its clinical research services...Read more on AuntMinnie.comRelated Reading:
MRI scoring system could predict liver transplant need
New MRI contrast material promises earlier liver diagnosis
2D shear-wave elastography diagnoses cirrhosis
New AI platform, CT scanner pace GE launches at RSNA 2018
Elastography helps diagnose pediatric liver fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 12, 2020 Category: Radiology Source Type: news
Acute on Chronic Liver Failure From Novel SARS-CoV-2 Acute on Chronic Liver Failure From Novel SARS-CoV-2
The authors report on a case of acute on chronic liver failure caused by SARS-CoV-2 infection in a patient with decompensated alcoholic cirrhosis.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
